Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
Shunyu Yao, Zixi Zhao, Weijun Wang, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases
Oana-Alina Petrariu, Ilda Czobor Barbu, Adelina-Gabriela Niculescu, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 38
A gut microbial signature for combination immune checkpoint blockade across cancer types
Ashray Gunjur, Yan Shao, Timothy Rozday, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 797-809
Open Access | Times Cited: 28
Supplementation of probiotic Bifidobacterium breve Bif11 reverses neurobehavioural deficits, inflammatory changes and oxidative stress in Parkinson's disease model
Sonali Valvaikar, Bhupesh Vaidya, Shikha Sharma, et al.
Neurochemistry International (2024) Vol. 174, pp. 105691-105691
Closed Access | Times Cited: 15
Gut microbiota as a key regulator of intestinal mucosal immunity
Jing Wang, Mei He, Ming Yang, et al.
Life Sciences (2024) Vol. 345, pp. 122612-122612
Closed Access | Times Cited: 13
Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects
Omar P. Vallejos, Susan M. Bueno, Alexis M. Kalergis
Trends in Molecular Medicine (2025)
Closed Access | Times Cited: 2
Interaction between dietary fiber and bifidobacteria in promoting intestinal health
Hui Wang, Xiaojun Huang, Huizi Tan, et al.
Food Chemistry (2022) Vol. 393, pp. 133407-133407
Closed Access | Times Cited: 41
Extracellular vesicles of the Gram-positive gut symbiont Bifidobacterium longum induce immune-modulatory, anti-inflammatory effects
Noa Mandelbaum, Lihan Zhang, Shaqed Carasso, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 36
Exploring the Benefits of Probiotics in Gut Inflammation and Diarrhea—From an Antioxidant Perspective
Qihui Li, Tenghui Zheng, Hanting Ding, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1342-1342
Open Access | Times Cited: 36
Probiotics for Neurodegenerative Diseases: A Systemic Review
Sandhya Ojha, Nil Patil, Mukul Jain, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 1083-1083
Open Access | Times Cited: 34
Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis
Sumel Ashique, Neeraj Mishra, Ashish Garg, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 27
Association between gut microbiota and psychiatric disorders: a systematic review
Carmen Grau-del Valle, Javier Fernández, Eva Solá, et al.
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 27
Sex Differences in Association Between Gut Microbiome and Essential Hypertension Based on Ambulatory Blood Pressure Monitoring
Preeti Dinesh Virwani, Gordon Qian, Matthew S.S. Hsu, et al.
Hypertension (2023) Vol. 80, Iss. 6, pp. 1331-1342
Open Access | Times Cited: 26
Modulating the Microbiome for Crohn’s Disease Treatment
Rachael Gowen, Ahmed Gamal, Luca Di Martino, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 828-840
Open Access | Times Cited: 24
Bifidobacterium longum R0175 protects mice against APAP-induced liver injury by modulating the Nrf2 pathway
Shengjie Li, Aoxiang Zhuge, Jiafeng Xia, et al.
Free Radical Biology and Medicine (2023) Vol. 203, pp. 11-23
Open Access | Times Cited: 22
Intestinal barrier dysfunction as a key driver of severe COVID-19
Efthymios P. Tsounis, Christos Triantos, Christos Konstantakis, et al.
World Journal of Virology (2023) Vol. 12, Iss. 2, pp. 68-90
Open Access | Times Cited: 21
Orally hierarchical targeting delivery systems relieve colitis by protecting host mitochondria and modulating gut microbiota
Liyun Xing, Xi Liu, Licheng Wu, et al.
Nano Today (2024) Vol. 55, pp. 102155-102155
Closed Access | Times Cited: 9
The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum
Jing Guo, Liping Li, Yue Cai, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiota
David Bars‐Cortina, Elies Ramon, Blanca Rius‐Sansalvador, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
Xinwei Xu, Dickson Kofi Wiredu Ocansey, Sanhua Hang, et al.
Gut Pathogens (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples
Boxun Zhang, Ke Liu, Haoyu Yang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 30
Mesenchymal stem cell-derived exosome mitigates colitis via the modulation of the gut metagenomics–metabolomics–farnesoid X receptor axis
Dickson Kofi Wiredu Ocansey, Zhiyu Zhang, Xinwei Xu, et al.
Biomaterials Science (2022) Vol. 10, Iss. 17, pp. 4822-4836
Closed Access | Times Cited: 30
Commensal Intestinal Protozoa—Underestimated Members of the Gut Microbial Community
Magdalena Dubik, Bartosz Pilecki, Jesper B. Moeller
Biology (2022) Vol. 11, Iss. 12, pp. 1742-1742
Open Access | Times Cited: 27
Mucoadhesive probiotic-based oral microcarriers with prolonged intestinal retention for inflammatory bowel disease therapy
Kairuo Wang, Qian Chen, Li Ding, et al.
Nano Today (2023) Vol. 50, pp. 101876-101876
Closed Access | Times Cited: 20
Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022
Cuilan Huang, Wujuan Hao, Xuyang Wang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 20
Low-dose glyphosate exposure alters gut microbiota composition and modulates gut homeostasis
Peter Lehman, Nicole Cady, Sudeep Ghimire, et al.
Environmental Toxicology and Pharmacology (2023) Vol. 100, pp. 104149-104149
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top